4366 — Daito Chemix Balance Sheet
0.000.00%
- ¥10bn
- ¥13bn
- ¥19bn
- 72
- 71
- 64
- 83
Annual balance sheet for Daito Chemix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3,254 | 3,423 | 2,394 | 2,252 | 2,775 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,818 | 4,399 | 4,201 | 4,778 | 4,873 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10,338 | 11,785 | 12,287 | 12,955 | 13,530 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,449 | 6,600 | 9,119 | 9,105 | 8,381 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 18,825 | 21,535 | 24,698 | 24,980 | 24,330 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,484 | 4,906 | 6,477 | 5,950 | 6,298 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,067 | 7,251 | 9,523 | 10,444 | 9,475 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 12,758 | 14,284 | 15,175 | 14,536 | 14,855 |
| Total Liabilities & Shareholders' Equity | 18,825 | 21,535 | 24,698 | 24,980 | 24,330 |
| Total Common Shares Outstanding |